Bausch Health Cos Income from Continuous Operations 2010-2024 | BHC
Bausch Health Cos income from continuous operations from 2010 to 2024. Income from continuous operations can be defined as a company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change
Bausch Health Cos Annual Income from Continuous Operations
(Millions of US $) |
| 2023 |
$-611 |
| 2022 |
$-212 |
| 2021 |
$-937 |
| 2020 |
$-559 |
| 2019 |
$-1,783 |
| 2018 |
$-4,144 |
| 2017 |
$2,404 |
| 2016 |
$-2,408 |
| 2015 |
$-288 |
| 2014 |
$880 |
| 2013 |
$-864 |
| 2012 |
$-116 |
| 2011 |
$160 |
| 2010 |
$-208 |
| 2009 |
$176 |
Bausch Health Cos Quarterly Income from Continuous Operations
(Millions of US $) |
| 2024-09-30 |
$-92 |
| 2024-06-30 |
$-1 |
| 2024-03-31 |
$-77 |
| 2023-12-31 |
$-47 |
| 2023-09-30 |
$-382 |
| 2023-06-30 |
$27 |
| 2023-03-31 |
$-209 |
| 2022-12-31 |
$-410 |
| 2022-09-30 |
$403 |
| 2022-06-30 |
$-139 |
| 2022-03-31 |
$-66 |
| 2021-12-31 |
$72 |
| 2021-09-30 |
$191 |
| 2021-06-30 |
$-593 |
| 2021-03-31 |
$-607 |
| 2020-12-31 |
$-152 |
| 2020-09-30 |
$70 |
| 2020-06-30 |
$-325 |
| 2020-03-31 |
$-152 |
| 2019-12-31 |
$-1,517 |
| 2019-09-30 |
$-48 |
| 2019-06-30 |
$-170 |
| 2019-03-31 |
$-48 |
| 2018-12-31 |
$-342 |
| 2018-09-30 |
$-351 |
| 2018-06-30 |
$-872 |
| 2018-03-31 |
$-2,579 |
| 2017-12-31 |
$512 |
| 2017-09-30 |
$1,300 |
| 2017-06-30 |
$-37 |
| 2017-03-31 |
$629 |
| 2016-12-31 |
$-512 |
| 2016-09-30 |
$-1,219 |
| 2016-06-30 |
$-304 |
| 2016-03-31 |
$-373 |
| 2015-12-31 |
$-387 |
| 2015-09-30 |
$52 |
| 2015-06-30 |
$-52 |
| 2015-03-31 |
$99 |
| 2014-12-31 |
$502 |
| 2014-09-30 |
$276 |
| 2014-06-30 |
$122 |
| 2014-03-31 |
$-20 |
| 2013-12-31 |
$125 |
| 2013-09-30 |
$-972 |
| 2013-06-30 |
$11 |
| 2013-03-31 |
$-28 |
| 2012-12-31 |
$-89 |
| 2012-09-30 |
$8 |
| 2012-06-30 |
$-22 |
| 2012-03-31 |
$-13 |
| 2011-12-31 |
$56 |
| 2011-09-30 |
$41 |
| 2011-06-30 |
$56 |
| 2011-03-31 |
$6 |
| 2010-12-31 |
$-31 |
| 2010-09-30 |
$-208 |
| 2010-06-30 |
$34 |
| 2010-03-31 |
$-3 |
| 2009-12-31 |
$73 |
| 2009-09-30 |
$40 |
| 2009-06-30 |
$24 |
| 2009-03-31 |
$39 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$3.012B |
$8.757B |
|
Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology.
|
